Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingrexuanfei plaster for children with community-acquired pneumonia
ChiCTR2300078964Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Xiao'er Qingrexuanfei Plaster in community-acquired pneumonia (CAP) (2 arms), sponsored by First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. Primary endpoints: Time of illness recovery, Time to lung rales disappearance and 5 more. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
Xiao'er Qingrexuanfei Plaster
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR2300078964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078964.